Inside Diagnostics Slides available of the AstraZeneca satellite symposium at ECP meeting Cologne

The Congress of the European Society of Pathology was held from 25 September to 29 September 2016 in Cologne, Germany, uniting pathologists from all over the world to reflect on recent developments in diagnostic and molecular pathology.

 

 

Professor Nicola Normanno presented his views on "Optimising testing pathways in NSCLC" followed by Dr Rachel Butler, who shared her experience on the "Adoption of liquid biopsies in clinical practice". Finally Professor Reinhardt Büttner explained the first results of the German ring trial initiative designed to help labs achieve optimal results in his talk titled "Ensuring quality EGFR testing in clinical practice".

 

Rudy Hovelinck
Diagnostics Manager AstraZeneca

 

 

NS ID 1014231 Approval Date 10/2016

Other Inside Diagnostic Articles

About the Author

Rudy Hovelinck

Diagnostics Manager AstraZeneca

rudy.hovelinck@astrazeneca.com

M. +32 (0) 476 42 22 58

Rudy Hovelinck obtained a scientific degree first in biochemistry at Ghent University and later in Molecular Biology at the ULB. Initially exploring the academic world in diverse fields as genetics, protein chemistry and virology, he soon realised that bridging scientific knowledge to the medical world was a more meaningful way of spending his professional life. This journey started in the field of pathology biomarker testing, introducing HER2 IHC and ISH testing for patient therapy selection and continued in the field of molecular oncology. Today at AstraZeneca he works as a diagnostics manager. In this role he is passionately contributing to the successful introduction of novel biomarkers and support current testing strategies for patient selection. In his own time he enjoys travelling with his family exploring the world and spending time close to nature. Specialties: Oncology, Anatomic Pathology, Biomarker Development, Medical Devices.